UNKNOWN MICRO CATHETERS
Report
- Report Number
- 2029214-2015-00438
- Event Type
- Death
- Date Received
- April 29, 2015
- Date of Event
- May 16, 2012
- Report Date
- March 31, 2015
- Manufacturer
- COVIDIEN (IRVINE)
- Product Code
- KRA
- PMA / PMN Number
- K093750
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- PHYSICIAN
Narratives
HTTP://WWW.NCBI.NLM.NIH.GOV/PUBMED/22591733 THIS REPORT WAS CREATED TO CAPTURE THE DEATH RELATED TO THE UNKNOWN MICROCATHETER. THE UNKNOWN CATHETERS WERE NOT RETURNED FOR ANALYSIS; THEREFORE, THE EVENT CAUSES COULD NOT BE DETERMINED. THE LOT HISTORY RECORD REVIEW WAS NOT POSSIBLE SINCE THE LOT NUMBERS WERE NOT REPORTED. INFORMATION RECEIVED FROM THE SAME ARTICLE AS MFRS: 2029214-2015-00435 2029214-2015-00434 2029214-2015-00436 2029214-2015-00433 (B)(4).
CITATION: ZHONG-SONG SHI, ET AL. FLOW CONTROL TECHNIQUES FOR ONYX EMBOLIZATION OF INTRACRANIAL DURAL ARTERIOVENOUS FISTULAE WAS FIRST PUBLISHED IN J NEUROINTERVENT SURG ON (B)(6) 2012. THE FOLLOWING REPORT WAS RECEIVED THROUGH LITERATURE REVIEW: BOTH ONYX 34 AND ONYX 18 WERE USED. ONYX 18 WAS UTILIZED WHEN DISTAL MIGRATION WAS FELT TO BE LESS LIKELY. ONYX COMPATIBLE MARATHON OR ECHELON 10 MICROCATHETER WAS NAVIGATED TO A POSITION AS CLOSE TO THE FISTULA AS OBTAINED. FIFTY-EIGHT PATIENTS UNDERWENT A TOTAL OF 84 EMBOLIZATION SESSIONS, 55 ADULT PATIENTS AND THREE PEDIATRIC PATIENTS. THERE WERE 33 WOMEN AND 25 MEN RANGING FROM 12 WEEKS TO 88 YEARS OF AGE. NEAR COMPLETE (90-99%) OCCLUSION OCCURRED IN 18 PATIENTS AND PARTIAL OCCLUSION IN FIVE PATIENTS. A PATIENT PRESENTED WITH INTRACEREBRAL HEMORRHAGE HAD A COMPLICATION OF MICROCATHETER ENTRAPMENT IN THE ONYX CAST AND RETENTION. THE FAMILY WITHDREW CARE DUE TO POOR PROGNOSIS. THE PATIENT EXPIRED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 282745 | UNKNOWN MICRO CATHETERS | CATHETER, CONTINUOUS FLUSH | KRA | COVIDIEN (IRVINE) |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Death |